Tuesday, July 08, 2014 8:46:55 PM
http://www.marketwatch.com/story/hemispherx-biopharma-and-bioclones-join-forces-in-effort-to-eradicate-hivaids-virus-based-on-recent-clinical-insights-of-wistar-institute-university-of-pennsylvania-2014-07-08
Maybe reason they are trying to keep price down?
Seems to me that if they are thinking of eradicating HIV, it would be huge. If they are working on this, I don't see the company going bankrupt... JMO
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM